OrthoPediatrics Corp.
General ticker "KIDS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $417.5M (TTM average)
OrthoPediatrics Corp. follows the US Stock Market performance with the rate: 47.4%.
Estimated limits based on current volatility of 1.8%: low 21.89$, high 22.69$
Factors to consider:
- Earnings expected soon, date: 2026-10-27 amc
- Total employees count: 602 (+7.1%) as of 2025
- US accounted for 78.9% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Pandemic risks, Economic downturns and volatility, Supply chain disruptions, Regulatory and compliance, Geopolitical risks
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.99$, 21.65$]
- 2026-12-31 to 2027-12-31 estimated range: [10.43$, 20.56$]
Financial Metrics affecting the KIDS estimates:
- Positive: with PPE of -15.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.18 <= 2.37
- Negative: negative Industry operating cash flow (median)
- Positive: -11.23 < Investing cash flow per share per price, % of -10.61
- Positive: 58.56 < Shareholder equity ratio, % of 68.14 <= 69.38
- Positive: Inventory ratio change, % of -0.22 <= 0
Short-term KIDS quotes
Long-term KIDS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $148.73MM | $204.73MM | $236.35MM |
| Operating Expenses | $175.48MM | $239.74MM | $275.59MM |
| Operating Income | $-26.75MM | $-35.01MM | $-39.24MM |
| Non-Operating Income | $5.44MM | $-6.92MM | $0.05MM |
| Interest Expense | $0.20MM | $2.62MM | $6.00MM |
| R&D Expense | $10.89MM | $11.03MM | $9.10MM |
| Income(Loss) | $-21.31MM | $-41.93MM | $-39.19MM |
| Taxes | $-0.34MM | $-4.11MM | $0.46MM |
| Net Income(Loss)* | $-20.97MM | $-37.82MM | $-39.65MM |
| Stockholders Equity | $377.02MM | $354.57MM | $346.60MM |
| Inventory | $105.85MM | $117.00MM | $133.79MM |
| Assets | $438.75MM | $473.21MM | $508.63MM |
| Operating Cash Flow | $-27.05MM | $-27.05MM | $-4.85MM |
| Capital expenditure | $18.98MM | $14.26MM | $11.11MM |
| Investing Cash Flow | $41.68MM | $-13.16MM | $-43.63MM |
| Financing Cash Flow | $7.30MM | $53.13MM | $23.98MM |
| Earnings Per Share** | $-0.92 | $-1.64 | $-1.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.